Plain-English translation of NCT07351071 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Signia Circular Stapler With Tri-Staple Technology, a surgical device designed to reconnect parts of the bowel after removing a diseased section during left-sided colon or rectal surgery. Researchers want to make sure this new stapling device is safe and works well by tracking how many patients develop complications—especially a leak at the connection site—within 30 days of their operation.
When surgeons remove part of the bowel due to disease, they need to reconnect the healthy ends. This trial exists to confirm that this newer stapling technology creates safe, leak-free connections and reduces surgical complications compared to what we know from past experience.
You likely qualify if…
You likely don't qualify if…
You would have your scheduled bowel surgery, during which your surgeon will use the Signia circular stapler to reconnect your bowel. After surgery, you will return for follow-up visits at your hospital or clinic at specific time points—typically around 30 days and 90 days after your operation—so the research team can check how well you are healing and make sure there are no complications at the connection site.
AI-generated summary from trial data · Sep 20, 2026 · Not medical advice
United States